Cargando…
Overall of kidney transplant recipients with a pretransplantation cancer history
No significant morbidity from recurrence cancer and no development of secondary type of cancers in pre‐existing malignancies. We must be careful about risk of rejection.
Autores principales: | Chargui, Soumaya, Braiek, Nesrine, Bacha, Mohamed Mongi, Harzallah, Amel, Hedri, Hafedh, Ouinissi, Mondher, Abderrahim, Ezzeddine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435231/ https://www.ncbi.nlm.nih.gov/pubmed/34532051 http://dx.doi.org/10.1002/ccr3.4810 |
Ejemplares similares
-
Gitelman syndrome, hypomagnesemia, and venous thrombosis: An intriguing association
por: Chargui, Soumaya, et al.
Publicado: (2022) -
Toward generalizing the use of artificial intelligence in nephrology and kidney transplantation
por: Badrouchi, Samarra, et al.
Publicado: (2022) -
Encapsulating Peritoneal Sclerosis after kidney Transplantation: Success of Medical Treatment
por: Gaied, Hanene, et al.
Publicado: (2021) -
Acquired epidermodysplasia verruciformis in renal‐transplant recipients
por: Gara, Soumaya, et al.
Publicado: (2020) -
POS-172 RENAL THROMBOTIC MICROANGIOPATHY , ANCA VASCULITIS AND COVID 19 INFECTION: AN INTRIGUING ASSOCIATION
por: Chargui, S., et al.
Publicado: (2021)